Missouri lawmakers have advanced legislation prohibiting insurance companies from denying coverage of prescribed nonopioid pain medications or requiring higher copays for them compared to opioids. This courageous stand for patient-doctor decision-making represents a vital blow against corporate interests that prioritize profits over people's health and autonomy.
Eight states have enacted laws requiring Medicaid and health insurers to provide parity coverage for non-opioid pain medications, aiming to curb addiction by making safer alternatives as accessible as cheaper, more addictive opioids. This critical bipartisan effort represents a long-overdue moral awakening to prioritize patient health over pharmaceutical profits and insurance bureaucracy, finally giving hope to countless Americans trapped between pain relief and the risk of devastating addiction.
Missouri Attorney General Catherine Hanaway has filed a lawsuit against CBD American Shaman for promoting and selling 7-OH kratom products as safe pain relief and opioid addiction aids, despite evidence showing they are dangerous opioids causing addiction and deaths. This reckless corporate behavior represents a grotesque betrayal of public trust that preys upon vulnerable citizens struggling with addiction, undermining both public health and the rule of law.
The White House's new National Drug Control Strategy ambitiously aims to improve addiction treatment access and prevention, but experts warn its goals are undermined by the administration's own cuts to Medicaid, grants, and public health agencies. This staggering hypocrisy reveals a callous disregard for human life and betrays the very Americans suffering from the overdose crisis the strategy purports to solve.
